Potential interactions between iloprost and SIN-1 on platelet aggregation and myocardial infarct size in vivo.
Nitric oxide and prostacyclin are endothelial-derived vasodilators which inhibit platelet aggregation in a synergistic manner. Experiments were designed to examine whether 3-morpholino-sydnonimine (SIN-1) and iloprost have synergistic cardioprotective actions and whether their effects on infarct size are related to inhibition of platelet aggregation. Anaesthetized rabbits (n = 9-10 per group) were subject to 40 min myocardial ischaemia followed by 3 h reperfusion. Infarct size (percentage of area at risk) was not altered significantly by 3 microg kg(-1) min(-1) SIN-1 (29.7 +/- 1.9%), but was reduced by 0.03 microg kg(-1) min(-1) iloprost (24.6 +/- 1.6%) and to a greater extent by the combination of SIN-1 and iloprost (18.8 +/- 1.7%), compared to controls (33.6 +/- 4.7%). In control rabbits, there were reductions in the ex vivo aggregation of platelets in response to ADP or collagen after ischaemia and reperfusion. SIN-1 and iloprost caused some alterations in platelet responses, but combined administration of both drugs did not produce greater effects. Although the reduction in myocardial infarct size was greatest with both drugs, this did not appear to be a synergistic interaction and was not dependent on the effects of the drugs on haemodynamics or platelet aggregation.
Aitchison
K A
KA
Department of Pharmacology and Therapeutics, The University of Liverpool, UK.
Coker
S J
SJ
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D003402:Creatine Kinase / Q000097:blood; D004357:Drug Synergism; D004562:Electrocardiography / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D016285:Iloprost / Q000494:pharmacology*; D008297:Male; D008981:Molsidomine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009203:Myocardial Infarction / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits
C002385:linsidomine; D008981:Molsidomine; D003402:Creatine Kinase; D016285:Iloprost